Literature DB >> 1145536

Idiopathic progressive pulmonary fibrosis.

D Davies, J S Crowther, A MacFarlane.   

Abstract

Five patients with progressive fibrotic lung disease are described. The dominant symptom was slowly increasing dyspnoea, and cough and sputum were not prominent. Marked weight loss was also a feature. There was severe restrictive impairment of ventilation with normal arterial gas tensions. The changes were confined to the upper parts of the lung in some but others had more generalized disease. The duration has varied so far from two to 17 years. The lung changes are considered to be due to dense progressive fibrosis. Necropsy in two confirmed this. Histologically there was monotonous fibrosis with lymphoid collections and secondary bronchiectasis, a picture similar to that found in association with ankylosing spondylitis. None of these patients had joint disease. Tuberculosis was excluded as a cause by exhaustive bacteriological tests and the failure of chemotherapy to stop deterioration. All other recognized types of infective and non-infective progressive lung fibrosis were also excluded, and this is not considered to be a variant of cryptogenic fibrosing alveolitis. Though these patients have many features in common they do not necessarily have the same pathogenesis. They are presented as an encouragement to further study.

Entities:  

Mesh:

Year:  1975        PMID: 1145536      PMCID: PMC470285          DOI: 10.1136/thx.30.3.316

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  3 in total

1.  Pulmonary fibrosis, pulmonary tuberculosis and ankylosing spondylitis.

Authors:  G K Crompton; S J Cameron; A O Langlands
Journal:  Br J Dis Chest       Date:  1974-01

2.  Allergic aspergillosis: review of 32 cases.

Authors:  A H Henderson
Journal:  Thorax       Date:  1968-09       Impact factor: 9.139

3.  Lung fibrosis and cavitation mimicking tuberculosis.

Authors:  D Davies
Journal:  Tubercle       Date:  1970-09
  3 in total
  9 in total

1.  Pleuroparenchymal fibroelastosis: report of two cases in Brazil.

Authors:  Paula Silva Gomes; Christina Shiang; Gilberto Szarf; Ester Nei Aparecida Martins Coletta; Carlos Alberto de Castro Pereira
Journal:  J Bras Pneumol       Date:  2017-01-23       Impact factor: 2.624

2.  Pleuroparenchymal fibroelastosis (PPFE)-like finding on CT in daily practice -prevalence and serial changes.

Authors:  Ryoko Egashira; Ken Yamaguchi; Tetsuya Kondo; Takahiko Nakazono; Shuichi Fukui; Hiroyuki Irie
Journal:  Eur J Radiol Open       Date:  2020-12-02

3.  Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis.

Authors:  J D Fulmer; W C Roberts; E R von Gal; R G Crystal
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

4.  Pulmonary disease in patients with Marfan syndrome.

Authors:  J R Wood; D Bellamy; A H Child; K M Citron
Journal:  Thorax       Date:  1984-10       Impact factor: 9.139

5.  Pleuroparenchymal Fibroelastosis: Its Pathological Characteristics.

Authors:  Jan H von der Thüsen
Journal:  Curr Respir Med Rev       Date:  2013-08

6.  Pleuroparenchymal Fibroelastosis: Its Clinical Characteristics.

Authors:  Kentaro Watanabe
Journal:  Curr Respir Med Rev       Date:  2013-06

Review 7.  Idiopathic Pleuroparenchymal Fibroelastosis.

Authors:  Martina Bonifazi; M Angeles Montero; Elisabetta A Renzoni
Journal:  Curr Pulmonol Rep       Date:  2017-01-27

8.  Severe and progressive platythorax disproportionate to lung fibrosis: A rare variant of idiopathic pleuroparenchymal fibroelastosis.

Authors:  Takato Ikeda; Yoshiaki Kinoshita; Yusuke Ueda; Tomoya Sasaki; Hisako Kushima; Hiroshi Ishii
Journal:  Respir Med Case Rep       Date:  2021-03-19

9.  The similarities and differences between pleuroparenchymal fibroelastosis and idiopathic pulmonary fibrosis.

Authors:  Hiroshi Ishii; Yoshiaki Kinoshita; Hisako Kushima; Nobuhiko Nagata; Kentaro Watanabe
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.